| |
Enterix Inc. is a US-based biotechnology company founded in 1997 that manufactures, markets, and distributes a leading-edge product for colorectal cancer screening called InSure®, InSure is a trademark of Enterix Inc., a fecal immunochemical test (FIT) that is a useful screening aid for detecting primarily lower gastrointestinal bleeding disorders that may be related to iron deficiency anemia, diverticulitis, ulcerative colitis, polyps, adenomas, colorectal cancers or other gastrointestinal lesions that can bleed. If present, this hidden (occult) blood in stool is typically passed in the feces to the toilet bowl water. The test’s method of detection (based on antibodies to hemoglobin) and its simple-to-use design result in sensitivity, specificity, and consumer compliance performance well in excess of the chemically based tests currently in use; the superiority of InSure® in these dimensions is supported by clinical trials.
Enterix technology is covered by U.S. Patents including Patent Nos. 6,221,678, 6,271,046, 6,869,804, & 6,977,173.
The InSure® FIT™ and InSure® Quik F I T™ are FDA cleared. Both tests are CLIA waived and have received strong endorsement from both clinicians and the medical products distribution industry in the USA. Quest Diagnostics completed the acquisition of Enterix Inc. in September 2006.
| |
|
| Customer Service Desk: |
800-531-3681 |
|
|
| Post: |
Enterix Inc.
236 Fernwood Avenue
Edison, NJ 08837
USA |
|
|
| Customer Service Desk: |
1800 55 65 75 (Toll-free in Australia) |
|
|
| Post: |
15/2 Eden Park Drive
North Ryde
NSW 2113
Australia |
|
Commitment to Compliance
Enterix, Inc. adheres to a policy of full compliance with the laws and regulations governing its business, not only as a legal obligation, but also because it is the right thing to do.
The Integrity Commitment is the foundation of Enterix, Inc.’s compliance program. The Integrity Commitment was created to protect and promote the Company’s commitment to compliance.
As a corporate priority, we expect and work to ensure that each of our employees understands and complies with all compliance policies and ethical guidelines. This includes adherence to the Company’s Code of Business Ethics (Code). The Code describes the standards of business conduct required of all Enterix, Inc. employees, executive officers and directors. The principles set forth in the Code are supported by the Company’s Vision and Values, the Integrity Commitment, the specific and detailed policies and practices contained in Your Compliance Policy Handbook and in other relevant Company policies and procedures. The company provides this framework of principles and procedures to help ensure consistency and alignment between what we say we value and what our actions demonstrate we value.
As a Company, we affirm our ongoing commitment to establishing policies and developing effective internal controls that will promote adherence to our standards of business ethics, our compliance policies and procedures, and the requirements of federal, state and private health care programs, and applicable FDA requirements.
Integrity Commitment
Code of Business Ethics
Please call 1-800-642-4657 ext. 4013 to obtain a hard copy of these documents.
Enterix Inc. is a Quest Diagnostics company.
For more information about Quest Diagnostics visit other areas on the Quest Diagnostics Corporate site:
|
